| Autor: |
Leite KME; Universidade Federal de Pernambuco, Pós-Graduação em Medicina Tropical, Recife, Pernambuco, Brazil., Lima KO; Universidade Federal de Pernambuco, Hospital das Clínicas, Recife, Pernambuco, Brazil.; European Virus Bioinformatics Center, Jena, Germany.; Instituto de Medicina Integral Prof. Fernando Figueira, Faculdade Pernambucana de Saúde, Recife, Pernambuco, Brazil., Ximenes RAA; Universidade Federal de Pernambuco, Pós-Graduação em Medicina Tropical, Recife, Pernambuco, Brazil.; Universidade de Pernambuco, Pós-Graduação em Ciências da Saúde, Recife, Pernambuco, Brazil., Albuquerque MFM; Fundação Oswaldo Cruz, Instituto de Pesquisa Aggeu Magalhães, Recife, Pernambuco, Brazil., Miranda-Filho DB; Universidade de Pernambuco, Pós-Graduação em Ciências da Saúde, Recife, Pernambuco, Brazil., Godoi ETAM; Universidade Federal de Pernambuco, Hospital das Clínicas, Recife, Pernambuco, Brazil., Montarroyos UR; Universidade de Pernambuco, Pós-Graduação em Ciências da Saúde, Recife, Pernambuco, Brazil., Lacerda HR; Universidade Federal de Pernambuco, Pós-Graduação em Medicina Tropical, Recife, Pernambuco, Brazil.; Universidade de Pernambuco, Pós-Graduação em Ciências da Saúde, Recife, Pernambuco, Brazil. |
| Abstrakt: |
Conditions related to the acquired immune deficiency syndrome (AIDS) are still a significant cause of morbidity and mortality among people living with HIV (PLHIV). Longer survival in this population were reported to increase the risk of developing noncommunicable chronic diseases (NCDs). This study aimed to estimate the survival and causes of death according to age group and sex among PLHIV monitored at two referral centers in the Northeastern Brazil. This is a prospective, retrospective cohort with death records from 2007 to 2018, based on a database that registers causes of death using the International Classification of Disease (ICD-10), which were subsequently coded following the Coding Causes of Death in HIV (CoDe). A total of 2,359 PLHIV participated in the study, with 63.2% being men, with a follow-up period of 13.9 years. Annual mortality rate was 1.46 deaths per 100 PLHIV (95% CI: 1.33 - 1.60) with a frequency of 20.9%. Risk of death for men increased by 49% when compared to women, and the risk of death in PLHIV increased by 51% among those aged 50 years and over at the time of diagnosis. It was observed that 73.5% accounted for AIDS-related deaths, 6.9% for non-AIDS defining cancer, 6.3% for external causes, and 3.2% for cardiovascular diseases. Among the youngest, 97.2% presented an AIDS-related cause of death. Highest frequency of deaths from neoplasms was among women and from external causes among men. There is a need for health services to implement strategies ensuring greater adherence to treatment, especially among men and young people. Moreover, screening for chronic diseases and cancer is essential, including the establishment of easily accessible multidisciplinary care centers that can identify and address habits such as illicit drug use and alcoholism, which are associated with violent deaths. |
